|
Reveal® Plus
Insertable Loop Recorder (ILR)
Reveal® Plus Insertable Loop Recorder (ILR) is the first and
only implantable patient- and automatically activated cardiac monitoring
system. Reveal Plus can record an ECG at the time of a syncopal episode
that may help rule in or rule out life-threatening arrhythmias.
Who could benefit from Reveal® Plus?
Patients who experience transient symptoms that may suggest a cardiac arrhythmia as well as patients with clinical syndromes or situations at increased risk for arrhythmias, including patients with:1,2
- Unexplained syncope
- Near syncope
- Episodic, recurrent palpitations
- Drug-refractory epilepsy, seizure-like events, and convulsions
Improved diagnosis
Reveal® Plus may help the physician diagnose where other tests fail
- Studies show that the rhythm captured during a spontaneous syncopal
event may not correlate to the rhythm recorded during tilt-table
induced syncopal events3,4,5
- The American College of Cardiology Foundation (ACCF)/American
Heart Association (AHA)6 and
the European Society of Cardiology (ESC)7 advise
the use of Reveal Plus in the management of syncope
Cost-effectiveness
Early use of Reveal® Plus may reduce syncope diagnosis
costs
- The cost of a primary ILR strategy is 26% less than that of conventional
testing in the diagnosis of recurrent, unexplained syncope8
- Reveal Plus-based treatments may lead to fewer hospitalization
days when compared to conventional testing-based treatments9
Simplicity
Reveal Plus is simple to implant and follow up
- Reveal Plus can be implanted in a short, minimally invasive outpatient
procedure
- With no restrictions due to external wires or recording pads,
Reveal Plus is designed to improve patient compliance
- During a syncopal episode, the ECG is captured via the one-touch
patient activator or the pre-programmed automatic activation option
- Data is easily retrieved and analyzed via the Medtronic programmer
References
- ACC/AHA Class
I Indications for Ambulatory ECG.
- Zaidi A, Clough
P, Cooper P, Scheepers B, Fitzpatrick AP. Misdiagnosis of epilepsy:
many seizure-like attacks have a cardiovascular cause. J
Am Coll Cardiol. July 2000;36(1):181-184.
- Deharo JC, Jego
C, Lanteaume A, Djiane P. An implantable loop recorder study
of highly symptomatic vasovagal patients: the heart rhythm observed
during a spontaneous syncope is identical to the recurrent syncope
but not correlated with the head-up tilt test or adenosine triphosphate
test. J Am Coll Cardiol. February 7, 2006;47(3):587-593.
- Moya A, Brignole
M, Menozzi C, et al. International Study on Syncope of Uncertain
Etiology (ISSUE) Investigators. Mechanism of syncope in patients
with isolated syncope and in patients with tilt-positive syncope. Circulation.
- Brignole M,
Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W. Lack
of correlation between the responses to tilt testing and adenosine
triphosphate test and the mechanism of spontaneous neurally mediated
syncope. Eur Heart J. September 2006;27(18):2232-2239.
- Strickberger
SA, Benson DW, Biaggioni I, et al. AHA/ACCF Scientific Statement
on
the evaluation of syncope: from the American Heart Association
Councils on Clinical
Cardiology, Cardiovascular Nursing, Cardiovascular Disease in
the Young, and Stroke,
and the Quality of Care and Outcomes Research Interdisciplinary
Working Group;
and the American College of Cardiology Foundation: in collaboration
with the Heart
Rhythm Society: endorsed by the American Autonomic Society. Circulation.
January 17,
- Brignole M,
Alboni P, Benditt DG, et al. Guidelines on management (diagnosis
and
treatment) of syncope – update 2004. Europace.
November 2004;6(6):467-537.
- Krahn AD, Klein
GJ, Yee R, Hoch JS, Skanes AC. Cost implications of testing strategy
in patients with syncope: randomized assessment of syncope trial. J
Am Coll Cardiol. August 2003;42(3):495-501.
- Farwell DJ,
Freemantle N, Sulke N. The clinical impact of implantable loop
recorders in patients with syncope. Eur Heart J. February
2006:27(3):351-356
|
|